August 2024

Electrification, the process of converting non-electric energy sources into electricity at the point of consumption, is rapidly transforming how we power our nation. This shift is driven by a confluence of factors: the introduction of new electric technologies, increasing environmental concerns, and supportive government policies across Australia. As a key strategy for achieving net-zero emissions, […]

The Australian sharemarket closed slightly higher on Monday amid a subdued trading session as investors focused on a series of company profit reports on the ASX. The benchmark S&P/ASX 200 Index rose by 0.1%, or 9.3 points, to 7980.4, with seven of the 11 sectors finishing in the red. Utilities led the gains, with stocks

It was a very different market reaction on Monday to the full-year results of plumbing supplier Reece (ASX:REH) than we saw for the interim back on 26 February. Then, a 5% lift in EBIT and a 20% jump in statutory earnings – 6% higher after dropping one-off items – but a steady dividend saw the

ANZ paid $4.9 billion for essentially the Queensland banking operations of Suncorp. On Monday, Queensland regional bank Auswide (ASX:ABA) and Tasmania’s MyState (ASX:MYS) unveiled what could only be called a “mergerette,” with a value for the all-paper deal around 80% less than the ANZ buy at approximately $755 million. The value of the merger is

Corporate Connect Research (CCR) has provided an initiation report on Mayfield Group Holdings (ASX:MYG). To see the full report click here.  Investment Summary Mayfield is a key player in the Australian market for electrical products and services, particularly for critical infrastructure. The company’s focus aligns with Australia’s broader infrastructure development goals, particularly the transition to

Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses progress with the company’s IMP761 drug, which is potentially active in more than 90% of autoimmune diseases. Peter Milios: I’m Peter Milios from the Finance News Network, and today we’re talking with Immutep (ASX:IMM). Immutep is trading under the ASX code “IMM” and has a

Australian steelmaker BlueScope (ASX:BSL) has defied expectations by increasing its final and full-year dividends for the 2023-24 financial year, even as it forecasts a dramatic profit slump in the first half of 2024-25. The company has issued a profit warning, predicting earnings before interest and tax (EBIT) to plummet by up to 60% in the

Suncorp (ASX:SUN) has forecast a slowdown in premium income growth for the current financial year, a development that may disappoint some investors. However, to offset this, shareholders can anticipate a substantial payout in the March quarter of next year from the $4.9 billion proceeds of the company’s bank sale to ANZ. Directors announced in Monday’s

A day after seeing its shares rise nicely on the peace pact with Synlait (ASX:SM1), its once key supplier, a2 Milk (ASX:A2M) saw its shares sold off heavily on Monday after reality hit in the form of a moderately OK 2023-24 results but weak outlook. The company saw its share fall more than 18% yesterday

Last week, Wall Street managed to erase all the losses from its rough start to August, leading to jokes that summertime might be better spent at the beach than worrying about market turmoil. However, even during the sell-off, one group remained steadfast—retail investors, whether they were enjoying the sun or glued to their screens. Retail